Pharmaceutical Business review

Atrium Innovations acquires Orthos Europe

The acquisition of Orthos represents Atrium’s second Netherlands-based acquisition for 2008. Atrium has previously announced the acquisition of MCO Health, a manufacturer and distributor of nutritional supplements.

AOV Orthomoleculaire Voedingssupplementen’s (AOV) products will be a value-added complement next to MCO Health’s flagship brand Orthica. The Orthica brand is specifically marketed to general practitioners and dietary specialists, and sold through pharmacists and other specialized outlets; while the AOV portfolio of products are marketed and sold primarily through complementary and alternative medicine practitioners and other professionals.

Serge Yelle, executive vice president of operations at Atrium, said: “With these two key brands, AOV and Orthica, Atrium has a solid platform from which to grow within the Benelux region.”